<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01881295</url>
  </required_header>
  <id_info>
    <org_study_id>1301013174</org_study_id>
    <nct_id>NCT01881295</nct_id>
  </id_info>
  <brief_title>Bioavailability of Potassium From Potatoes and Potassium Gluconate</brief_title>
  <acronym>Potato</acronym>
  <official_title>Bioavailability of Potassium From Potatoes and Potassium Gluconate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alliance for Potato Research and Education (APRE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Purdue University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the effect of sources of potassium on uptake and the effect
      of potassium on blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will compare uptake of potassium from three different doses and sources;
      supplements (720, 1440 and 2160 mg) potatoes (720, 1440 and 2160 mg) or French fries (2160
      mg).

      During 9 phases, participants will consume a controlled diet with the supplements, potato or
      french fries (every other week for 5 days). On the 4th day, blood and urine samples will be
      taken to monitor potassium uptake and excretion. Measures of blood pressure will be analyzed
      at defined time points throughout the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bioavailability of Potassium</measure>
    <time_frame>5 days</time_frame>
    <description>After 4 days of acclimation to the supplementation, absorption of potassium will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure Response to Potassium</measure>
    <time_frame>6 days</time_frame>
    <description>Differences in blood pressure will be measured between levels of potassium consumption.</description>
  </secondary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Potassium Bioavailability</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will consume tablets containing no potassium in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose potassium gluconate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 720 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose potassium gluconate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 1440 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose potassium gluconate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 2160 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose potato</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 720 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose potato</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 1440 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose potato</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 2160 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose French fries</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume 2160 mg potassium in the form of french fries daily in addition to a basal diet containing 2336 mg potassium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Basal diet control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume a basal diet containing 2336 mg potassium daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo control</intervention_name>
    <arm_group_label>Placebo control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low dose potassium gluconate</intervention_name>
    <arm_group_label>Low dose potassium gluconate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Medium dose potassium gluconate</intervention_name>
    <arm_group_label>Medium dose potassium gluconate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High dose potassium gluconate</intervention_name>
    <arm_group_label>High dose potassium gluconate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low dose potato</intervention_name>
    <arm_group_label>Low dose potato</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Medium dose potato</intervention_name>
    <arm_group_label>Medium dose potato</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High dose potato</intervention_name>
    <arm_group_label>High dose potato</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High dose French fries</intervention_name>
    <arm_group_label>High dose French fries</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Basal diet control</intervention_name>
    <arm_group_label>Basal diet control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to adhere to the visit schedule, protocol requirements and available to complete
             the study

          -  Normotensive men and women

          -  Aged 20-60 years

          -  BMI of 15-35

        Exclusion Criteria:

          -  Medication to treat hypertension or hypotension

          -  Medication known to affect electrolyte metabolism or contain high levels of potassium
             or sodium

          -  smoke cigarettes or use illegal drugs

          -  Hypertension or hypotension

          -  Diseases known to affect potassium metabolism

          -  Pregnant

          -  Allergic to nuts
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Connie M Weaver, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Purdue University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berdine R Martin, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Purdue University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Purdue University</name>
      <address>
        <city>West Lafayette</city>
        <state>Indiana</state>
        <zip>47907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2013</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Purdue University</investigator_affiliation>
    <investigator_full_name>Berdine Martin</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Potassium</keyword>
  <keyword>Potato</keyword>
  <keyword>French Fries</keyword>
  <keyword>Bioavailability</keyword>
  <keyword>Blood Pressure</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

